Objectives Recent studies suggest that a combination of enamel matrix derivative (EMD) with grafting material may improve periodontal wound healing/regeneration. Newly developed calcium phosphate (CaP) ceramics have been demonstrated a viable synthetic replacement option for bone grafting filler materials. Aims This study aims to test the ability for EMD to adsorb to the surface of CaP particles and to determine the effect of EMD on downstream cellular pathways such as adhesion, proliferation, and differentiation of primary human osteoblasts and periodontal ligament (PDL) cells. Materials and methods EMD was adsorbed onto CaP particles and analyzed for protein adsorption patterns via scanning electron microscopy and high-resolution immunocytochemistry with an anti-EMD antibody. Cell attachment and cell proliferation were quantified using CellTiter 96 One Solution Cell Assay (MTS). Cell differentiation was analyzed using real-time PCR for genes encoding Runx2, alkaline phosphatase, osteocalcin, and collagen1α1, and mineralization was assessed using alizarin red staining.
Introduction
Over the past 20 years, significant progress has been made in the development of new bone grafts and bone substitute materials for the treatment of bony defects [1] . Bone grafts are commonly used in oral surgeries to fill voids, augment bone, facilitate or enhance bone repair, provide mechanical membrane support, stabilize blood clots, and serve as a vehicle for antibiotics and growth factors. Although autogenous bone grafts are considered the gold standard, a variety of biological and synthetic materials, including bone allografts (freeze dried from human donors), xenografts (from animals or plants), and alloplasts (synthetically fabricated such as hydroxyapatite, beta tricalcium phosphate, biphasic calcium phosphate, polymers and bioactive glass), are extensively being studied [2] [3] [4] [5] in order to avoid the drawbacks and limitations of autogenous bone which include donor site morbidity and increased surgical costs.
In order to improve the osteoconductive properties of synthetic bone grafts, recent attempts at combining alloplasts with autogenous bone or growth factors have been utilized to establish osteoinductive capacity [1, [6] [7] [8] [9] . Nevertheless, the inability to harvest large quantities of autogenous bone and the large expenses and short half-lives of growth factors still pose a clinical challenge [10] . Yuan et al. were one of the first to show that different synthetic biomaterials were able to induce ectopic bone formation in various animal models, and further studies have reconfirmed these observations [11] . Recently, a calcium phosphate (CaP) ceramic sintered at low temperatures was implanted in dogs and sheep and demonstrated as effective as autologous bone in treating bone defects [12, 13] . Bone induction by CaP, although shown in some studies, is in general not the standard mode of action for the large majority of CaP products.
Similarly, the use of an enamel matrix derivative (EMD) composed primarily of amelogenin proteins has successfully been utilized for its ability to regenerate periodontal tissues including cementum, periodontal ligament, and bone [14] . Although histological and controlled clinical studies have provided evidence for periodontal regeneration and substantial clinical improvements following the use of EMD in intrabony defects [14] , concerns have been expressed regarding the viscous nature of EMD, which may not be sufficient to prevent flap collapse in periodontal defects with a complicated anatomy thus limiting the amount of space available for periodontal regeneration [15, 16] . In order to overcome this potential limitation and improve the clinical results obtained with EMD, recent attempts at combining various types of grafting materials with EMD have been investigated [5, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . While the majority of clinical [17, 21, 22, [25] [26] [27] [28] and animal studies [20, 23, 24] reveal a potential benefit for a combination approach, others have failed to demonstrate an advantage [5, 18, 19, 29, 30] .
Therefore, the aim of the present study was to assess the ability for a particular CaP bone ceramic to support osteoblast and periodontal ligament (PDL) cell attachment, proliferation, and differentiation on their surfaces. Furthermore, the ability for EMD to adsorb to the surface of CaP particles as well as influence cell behavior will be compared to a control and blood-adsorbed samples.
Materials and methods

Scanning electron microscopy
Scanning electron microscopy (SEM) was used to visualize the surface topographies of CaP particles (Institut Straumann AG, Basel, Switzerland) adsorbed with blood and EMD (Emdogain, Institut Straumann AG, Basel, Switzerland) or left unaltered (control). CaP particles were fixed in 1 % glutaraldehyde and 1 % formaldehyde. Following dehydration with ethanol, samples were critical point dried (Type M.9202, Critical Point Dryer, Roth & Co., Hatfield, PA, USA) followed by overnight drying. Next, samples were sputter coated (DCM-010, Balzers, Liechtenstein) with a 10-nm layer of gold and analyzed microscopically using a scanning electron microscope (XL30 FEG, Philips, Eindhoven, Netherlands) to determine surface variations between samples.
Histologic processing
In order to determine the ability for EMD to adsorb and penetrate into CaP particles, CaP particles + EMD were fixed in 1 % glutaraldehyde and 1 % formaldehyde, buffered with 0.08 M sodium cacodylate (pH 7.4). The samples were then washed in 0.1 M sodium cacodylate buffer containing 5 % sucrose, pH 7.3, and processed for embedding in LR White resin (Fluka, Buchs, Switzerland). Semithin LR White survey sections (1 μm thick) were cut with glass and diamond knives on a Reichert Ultracut E microtome (Leica Microsystems, Glattbrugg, Switzerland), stained with toluidine blue and basic fuchsin, and observed in a Zeiss Axioplan microscope (Carl Zeiss, Gottingen, Germany).
High-resolution immunocytochemistry
The high-resolution protein A-gold technique was used for the immunocytochemical localization of EMD to determine the ability for EMD to adsorb the surface and penetrate CaP particles as previously described [31] . Thin (80-100 nm) sections of LR Whiteembedded tissues were cut with a diamond knife, mounted on formvar-and carbon-coated nickel grids, and then floated on a drop of 0.01 M phosphatebuffered saline (PBS), pH 7.3, containing 1 % ovalbumin (Fluka, Buchs, Switzerland) in order to saturate nonspecific binding sites. Sections were transferred and incubated for 1 h on a drop of affinity-purified rabbit anti-EMD polyclonal antibody [31] diluted with PBS. Following incubation with the primary antibody, the grids were rinsed with PBS, floated on 1 % ovalbumin in PBS for 10 min, and then incubated for 30 min with protein A-gold complex prepared with gold particles of approximately 10 nm (Drs. G Posthuma and J.W. Slots, University Medical Center Utrecht, Utrecht, Netherlands). Thereafter, the grids were washed with PBS and distilled water, contrasted with uranyl acetate and lead citrate, and examined in a Philips 300 transmission electron microscope operated at an accelerating voltage of 60 kV.
EMD adsorption to bone grafting particles for in vitro experiments
EMD was prepared according to Institut Straumann AG standard operating protocols as previously described [31] . Thirty milligrams of EMD was dissolved in 3 ml of sterile 0.1 % acetic acid at 4°C. For experiments, stock EMD was diluted 100× in 0.1 M carbonate buffer at 4°C to a working concentration of 100 μg/ml. One milliliter of EMD solution was incubated overnight at 4°C into 24-well culture dishes containing 100 mg of CaP particles (Institut Straumann, AG, Basel, Switzerland). Following incubation, dishes were rinsed twice with 1 ml PBS.
Osteoblast and PDL cell isolation and differentiation
Human bone chips were cultured according to an explant model under a protocol approved by the Ethics Committee, Katon Bern, Switzerland. PDL cells were obtained from the middle third portion of three teeth extracted from healthy patients with no signs of periodontal diseases at the Department of Orthodontics, Dental Clinic, University of Bern, as previously described [31] . Primary human osteoblasts and PDL cells were detached from the tissue culture plastic using trypsin solution (Invitrogen, Basel, Switzerland). Cells used for experimental seeding were from passages 4-6. Primary osteoblasts and PDL cells were separately seeded at a density of 10,000 cells into their respective 24-well culture plates for cell attachment and cell proliferation experiments and 50,000 cells for real-time PCR and alizarin red experiments. For experiments lasting longer than 5 days, the medium was replaced twice weekly.
Adhesion and proliferation assays
Primary osteoblasts and PDL cells were quantified using the CellTiter 96 One Solution Cell Assay (MTS; Promega, Madison, WI, USA) as previously described [32] . Cells were seeded on 100 mg of CaP per well in 24-well plates at a density of 10,000 cells per well. At 4 and 8 h for cell adhesion and 1, 2, 3, and 5 days for cell proliferation, cells were washed with PBS incubated with 80 μl of CellTiter96 aqueous solution dissolved in 400 μl of PBS. After 4 h of culture, the cell viability was determined by measuring the absorbance at 490 nm on a 96-well plate reader. Experiments were performed in triplicate with three independent experiments for each condition. Data (±SE) were normalized to control samples.
Real-time RT-PCR
Real-time RT-PCR was employed to quantify the total RNA of PDL cell and osteoblast-related differentiation markers. Total RNA was isolated using TRIZOL reagent and RNAeasy Mini kit (Qiagen, Basel, Switzerland) at 3, 7, and 14 days of osteoblast differentiation markers. Primer and probe sequences for genes encoding alkaline phosphatase (ALP, Hs01029144_m1), runt-related transcription factor 2 (Runx2, Hs00231692_m1), collagen1α1 ( C O L 1 A 1, H s 0 10 28 9 70 _m 1 ) , os t e oc alc i n (O C , Hs01587814_g1), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Hs03929097_g1) were purchased as predesigned gene expression assays (Taqman, Applied Biosystems, Rotkreuz, Switzerland). Real-time RT-PCR was performed using 20 μl final reaction volume of One step Master Mix kit as previously described [33] . RNA quantification was performed using a Nanodrop 2000c, and 100 ng of total RNA was used per sample well. All samples were assayed in triplicate, and three independent experiments were performed. The ΔΔCt method was used to calculate gene expression levels normalized to GAPDH values and calibrated to control CaP particles. Data were log-transformed prior to analysis by two-way ANOVA with Bonferroni test using Graphpad Software v. 4 (La Jolla, CA, USA).
Alizarin red quantification
Alizarin red staining was performed to determine the presence of extracellular matrix mineralization after 21 days. Osteoblasts were seeded at a density of 50,000 cells per 24-well culture dish onto control, blood-adsorbed, and EMD-adsorbed CaP particles. After 21 days, cells were fixed in 96 % ethanol for 15 min and stained with 0.2 % alizarin red solution (Sigma-Aldrich, Basel, Switzerland) in water (pH 6.4) at room temperature for 1 h. Samples representing background staining (CaP particles without cells) were treated identically. Alizarin red was dissolved using a solution of 20 % methanol and 10 % acetic acid in water for 15 min. Liquid was then transferred to cuvettes and read on a spectrophotometer at a wavelength of 450 nm as previously described [34] . After subtraction of background, absorbance values were normalized to DNA content. Data were analyzed for statistical significance using one-way analysis of variance with Tukey's test.
Results
Scanning electron microscopy
Control CaP particles varied in micro and macro topographies on the surface of grafting particles with the odd interconnected pore observed within a graft particle ( Fig. 1(A, B) ). The high-resolution SEM images demonstrated an extremely rough surface with many variations in surface nanotopographies ( Fig. 1(C) ). Surface adsorption with blood revealed strong attachment of red blood cells (RBCs) and a fibrin matrix to the surface of CaP particles ( Fig. 1(D) ). The accumulation of hundreds of RBCs can be observed at magnification ×200 ( Fig. 1(E)) . Interestingly, RBCs demonstrate variable affinity to the surface of CaP particles with certain graft regions being preferentially covered ( Fig. 1(E) ). At high magnification (×6,400), a fibrin/protein network surrounding RBCs could be observed with many of the nanotopographies present in the control sample no longer visible ( Fig. 1  (F) ). The effect of surface adsorption with EMD revealed substantial protein deposition on the surface of CaP particles (Fig. 1(G) ). Despite widespread protein attachment, inhomogeneity of EMD adsorption was observed ( Fig. 1(H) ). High-resolution images revealed a network of EMD protein fibers spanning over the surface of CaP particles with variable protein density covering the surface (Fig. 1(I) ). Transmission electron microscopy High-resolution immunohistochemistry was then performed using gold labeling for an anti-EMD antibody to determine the ability for EMD to adsorb and penetrate into CaP grafting particles (Fig. 2) . CaP particles pre-adsorbed with EMD stained positively for anti-EMD at the surface of CaP particles. Gold labeling was rarely present on the interior of CaP particles demonstrating an inability for EMD proteins to penetrate to the interior regions of grafting particles.
Osteoblast and PDL cell attachment and proliferation
In order to demonstrate cell compatibility with CaP particles, primary human osteoblasts and PDL cells were observed via SEM 24 h following post-seeding (Fig. 3) . Osteoblasts and PDL cells attached on all control, bloodadsorbed, and EMD-adsorbed CAP particles (Fig. 3) . Cells seeded on EMD initially demonstrated a greater ability to attach and spread on CaP grafting particles (Fig. 3(E,  F) ). Analysis of MTS cell number revealed significantly higher osteoblast and PDL cell number at 4 and 8 h post-seeding on EMD-adsorbed CaP particles when compared to blood-adsorbed and control surfaces (Fig. 4a, b) . At 24 h post-seeding, cell number approached 100 % cell attachment levels for all treatment modalities (Fig. 4a, b) . EMD displayed a significant increase on cell proliferation for both PDL cells (Fig. 5c) and osteoblasts (Fig. 5d ) at 3 and 5 days postseeding. Interestingly, EMD had a more pronounced effect on PDL cells at 3 and 5 days when compared to osteoblasts at equivalent time points (p<0.05). 
Osteoblast differentiation
Primary human osteoblasts and PDL cells were assessed for ALP, COL1A1, Runx2, and OC gene expression at time points 3, 7, and 14 days (Fig. 5) . ALP levels were significantly higher on EMD-adsorbed CaP particles at 7 and 14 days postseeding for osteoblasts (Fig. 5a ) and PDL cells (Fig. 5b) . COL1A1 mRNA levels demonstrated higher, nonsignificant expression at all time points for osteoblast and PDL cells seeded on EMD-adsorbed CaP particles when compared to control and blood-adsorbed samples (Fig. 5c, d) . Analysis of Runx2 gene expression showed significant increases in mRNA levels at both 7 and 14 days post-seeding for PDL cells seeded on EMD when compared to control and bloodadsorbed CaP particles (Fig. 5f) . No significant differences were observed for Runx2 gene expression in osteoblasts (Fig. 5e) . OC mRNA levels showed significant increases for both PDL cells and osteoblasts seeded on EMD-adsorbed CaP particles at 7 and 14 days post-seeding when compared to control and blood-adsorbed particles (Fig. 5g, h ). In order to further determine the effects of EMD on osteoblast differentiation, mineralization was assessed via alizarin red staining. At 21 days post-seeding, EMD significantly increased alizarin red staining when compared to control and blood-adsorbed particles (Fig. 6) .
Discussion
It was recently demonstrated that a biphasic calcium phosphate sintered at a relatively low temperature has a high ability to promote ectopic bone formation when compared to other synthetic grafting particles [35] . Two main material factors, microporosity and dissolution rate, are suggested to be the reason for the different abilities for synthetic bone grafts to induce ectopic bone formation [35] . The induction of bone formation by CaP ceramics is thought to be controlled via a secondary mechanism by which CaP grafts have a high affinity for proteins including bone morphogenetic proteins which are then able to induce bone formation.
In the present study, we tested the ability for CaP bone grafts to adsorb enamel matrix proteins. EMD is a widely used biologic agent capable of enhancing periodontal wound healing/regeneration [14] . The in vitro roles have been well documented in both osteoblasts and PDL cells [36] . EMD has a significant influence on cell adhesion, cell proliferation, and cell differentiation of many cell types by mediating cell attachment, spreading, proliferation, and survival as well as expression of transcription factors, growth factors, cytokines, extracellular matrix constituents, and other molecules involved in the regulation of bone remodeling [36, 37] . In the present study, it was determined by SEM that EMD readily adsorbed to the surface of CaP grafting particles and that the protein was readily observed via TEM when an anti-EMD antibody was utilized (Fig. 2a) . These results are comparable to those described by Gestrelius et al. who demonstrated that EMD forms insoluble spherical complexes on the surfaces of hydroxyapatite, collagen, and denuded root surfaces [38] . Because CaP are dense grafting [1] particles, little to no EMD was able to penetrate the interior of these grafting materials. In contrast, we have previously demonstrated that EMD adsorbed onto a natural bone mineral (NBM) was able to adsorb and penetrate into the innermost regions of NBM particles [31] . The ability for EMD adsorption to the innermost regions of a grafting particle to influence cell behavior remains uninvestigated. Further research is also necessary to evaluate the impact of higher/lower macro and micro surface porosity on protein adsorption of EMD and how this may affect downstream cellular pathways.
Following confirmation of protein adsorption of EMD to the surface of the CaP grafting material, we then sought to determine the cellular behavior of osteoblast and PDL cells seeded on CaP particles in the presence or absence of EMD and blood. The major component of EMD, amelogenins, is a family of hydrophobic proteins that account for more than 90 % of the total protein content and has previously been described as a cell adhesion molecule [38] . Several reports have confirmed that other molecules contained in EMD contain integrin-binding regions by demonstrating that PDL cells attach to BSP-like molecules contained in EMD through αvβ3 integrins [39] . In this study, EMD was able to significantly increase PDL cell and osteoblast attachment to CaP particles at early time points of 4 and 8 h post-seeding. Furthermore, EMD had a significant influence on cell proliferation and differentiation for both PDL cells and osteoblasts (Fig. 4) . Interestingly, higher increases in cell proliferation and differentiation were observed in PDL cells when compared to osteoblasts. These findings are in accordance with Dean et al. who suggested that EMD increases Fig. 6 Alizarin red staining of primary human osteoblasts seeded on control, blood-adsorbed, and EMD-adsorbed CaP particles. EMD significantly increased osteoblast mineralization 21 days post-seeding. Data shown are the average value from three independent experiments (three replicates per experiment)±SE (*p<0.05) cell differentiation of mesenchymal cells early in their differentiation process when compared to a more differentiated cell type [40] . Since enamel matrix proteins are embryologically utilized to differentiate cells early in their maturation states prior to root formation, it is logical to assume that EMD as an enamel extract would also have a similar effect on cells with a higher proportion of undifferentiated progenitor cells.
Although previous clinical and animal studies have demonstrated variability among treatment with a combination of grafting particle and EMD, under the present in vitro conditions, EMD was able to stimulate PDL cell and osteoblast attachment, proliferation, and differentiation. Future in vivo and clinical studies are necessary to further elucidate the effects of this combination approach for clinical use.
